The Effect of Neurorehabilitation Therapy on Postural Control, Mobility and Quality of Life in Multiple Sclerosis Patients

Somogy Megyei Kaposi Mór Teaching Hospital

Status: Completed

Conditions: Multiple Sclerosis, Primary Progressive; Multiple Sclerosis, Chronic Progressive

Treatments: Other: Physiotherapy; Other: Neurorehabilitation

Study type: Interventional

Funder types: Other

Identifiers

NCT03424538

IKEB008/2017

Details and patient eligibility

About

Abstract Introduction: Postural control disorders are the most common motor disorder associated with multiple sclerosis.

Objective: The aim of this study is to demonstrate the potential for improvement of postural control, motion performance and quality of life in patients with multiple sclerosis who are performing a special neurorevolutionary balancing program.

Intervention: The treated group (n = 15) performed five times a week for the treatment we defined. (60 minutes per day). The experimental group performed movements using the Xbox 360 and Kinect consoles. The study team participated in 25 sessions, five times a week. The duration of treatment was 5 weeks.The MStp group (n=14) participated in a 5-week physiotherapy course. The general treatment consisted of strengthening, stretching and walking correction. During the 5-week period, 25 patients attended training. One treatment takes 60 minutes. Sensory Organisation Test / Body Sway at the end of the baseline and treatment protocol is used to evaluate each patient. The quality of life mapping was measured by subjective tests (EQ-5D-5L, ADL). To assess the depressive state, a Beck depression questionnaire was used. Balance and motion performance were used by the Berg Balance Test and 6Minutes Walk Test. The results were compared with the control group results (n = 14) and showed improvement in overall balance and motion performance.

Enrollment: 2 patients

Sex: All

Ages: 35 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Multiple Sclerosis
• instability problem

Exclusion criteria

• Severe heart problems, severe demeanor, alcoholism, drug problems

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

2 participants in 3 patient groups

MSt

Experimental group

Description:

The MSt group that received 5 weeks of intensive therapy.

Treatment:

Other: Neurorehabilitation

MSc

No Intervention group

Description:

The MS controll group that did not receive treatment.

MStp

Experimental group

Description:

The MStp Group performs a traditional physiotherapy for 5 weeks.

Treatment:

Other: Physiotherapy